Delivering the Promise of 'Omic' Technologies To Predict and Treat Disease

The MURDOCK Study (Measurement to Understand the Reclassification of Disease of Cabarrus/Kannapolis) is a multi-tiered, long-term genomic study funded by a $35 million grant from David Murdock, the founder of the NCRC.

The MURDOCK Study is designed to use advanced technologies to identify genomic linkages – the study of genes, proteins, and other biomarkers – within and across diseases and disorders such as hepatitis C, cardiovascular disease, obesity, and osteoarthritis. The MURDOCK study builds on the promise of –omic technologies, which are housed at the NCRC, and the expertise of Duke researchers to improve the way debilitating diseases are predicted and treated. The MURDOCK Study has the potential to rewrite the textbook of modern medicine to reflect scientific and clinical advances of the 21st century.

Through biobanking the biological samples of volunteers from the Kannapolis area, the MURDOCK study is able to study medical histories, demographics and other descriptors to help Duke researchers and partners better understand diseases that commonly affect the public health. Already, the MURDOCK Study is breaking new ground in the understanding of and potential treatments for hepatitis C, osteoarthritis, coronary heart disease, and Multiple Sclerosis.

For more information, visit https://www.murdock-study.com/about.